February 6, 2017
ForFarmers nominates Chr. Hansen CEO as member of supervisory board
ForFarmers has announced that its supervisory board has resolved to nominate Cees de Jong as member of the entity.
The nomination will be submitted to an annual general meeting of shareholders of April 26, 2017. Henk Mulder will stand down on the same day in line with the retirement schedule.
Cees de Jong is currently president and CEO of the globally operating Danish stock listed bioscience company Chr. Hansen that develops sustainable solutions for the food, nutritional, pharmaceutical and agricultural industries.
Before he was appointed to CEO of Chr. Hansen in 2013, de Jong held various management and board positions in the biopharmaceutical and food industries. His professional career started in 1989 after he had obtained his Master of Business Administration (MBA) and his Medical Doctorate degree from Erasmus University in Rotterdam, the Netherlands.
The first company he joined was Gist-Brocades. When the company was acquired by DSM in 1998, Cees de Jong stayed on and was appointed to president of the Business Group Anti-Infectives. In 2000, he moved to Campina to manage the Industrial Products division, and from 2003 to 2007, de Jong worked for Quest International as president of the Flavour division and member of the board. Subsequently, he became chief operating officer and member of the board of the biotech company Crucell, which was taken over by Johnson & Johnson in 2011.
'Given Cees de Jong's broad international experience in large branch related organisations, we are extremely pleased to be able to nominate him as a member of our Supervisory Board. We are of the opinion that our Board will be afforced when he takes office', states Jan Eggink, chairman of the supervisory board of ForFarmers.